Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiber Laboratories was a specialty pharmaceutical company based in Suwanee, Georgia, that focused on the respiratory and allergy therapeutic areas. The company specialized in the development and commercialization of branded generic prescription products, particularly multi-ingredient cough and cold medications. Its portfolio included products such as Tiber-D, Tiber-T, and Tussicaps, which utilized combinations of decongestants, antihistamines, anticholinergics, and antitussives. Although the company was active throughout the 2010s, it has since been administratively dissolved. Tiber Laboratories aimed to provide cost-effective alternatives to major brand-name respiratory treatments for primary care patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiber Laboratories.